Akura Medical Secures $53 Million in Series C Funding to Revolutionize Venous Thromboembolism Care Akura Medical has closed a $53 million Series C funding round to support its innovative TEV treatment technologies and regulatory approvals.

Akura Medical Secures $53 Million in Series C Funding to Revolutionize Venous Thromboembolism Care #USA #Los_Gatos #Shifamed #Akura_Medical #Katana_System

Akura Medical Secures $53 Million in Series C Funding to Advance Thrombectomy Solutions Akura Medical has raised $53 million in Series C funding to enhance thromboembolic care technology, including the Katana Thrombectomy System.

Akura Medical Secures $53 Million in Series C Funding to Advance Thrombectomy Solutions #USA #Los_Gatos #thrombectomy #Akura_Medical #Katana_System

Akura Medical Secures $53 Million Series C Funding for VTE Solutions Development Akura Medical announces $53M funding designed to advance their advanced venous thromboembolism care solutions, enhancing patient outcomes.

Akura Medical Secures $53 Million Series C Funding for VTE Solutions Development #USA #Los_Gatos #Shifamed #Akura_Medical #Katana_System